Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nitto Denko Technical Corporation (NDT) is a California-based research and development subsidiary of the Japanese multinational Nitto Denko Corporation. The company specializes in the development of advanced drug delivery systems, particularly focusing on nucleic acid-based therapeutics such as siRNA. NDT leverages its expertise in polymer chemistry and lipid nanoparticle technology to create targeted therapies for chronic diseases, including liver and lung fibrosis. Their lead programs utilize a proprietary delivery platform to silence specific genes involved in disease progression. NDT plays a critical role in Nitto's global healthcare strategy by bridging innovative material science with clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nitto Denko Technical.